Cancer risk among patients with type 2 diabetes: A real-world study in Shanghai, China2?????????????:????????????

被引:54
|
作者
Qi, Jiying [1 ]
He, Ping [2 ]
Yao, Huayi [2 ]
Song, Ruogang [1 ]
Ma, Chenglong [1 ]
Cao, Min [1 ]
Cui, Bin [1 ]
Ning, Guang [1 ]
机构
[1] Shanghai Jiao Tong Univ, Shanghai Clin Ctr Endocrine & Metab Dis, Shanghai Inst Endocrine & Metab Dis, Ruijin Hosp,Sch Med, 197 Ruijin 2nd Rd, Shanghai 200025, Peoples R China
[2] Shanghai Hosp Dev Ctr, Shanghai Hosp Link Ctr, Shanghai, Peoples R China
基金
国家重点研发计划;
关键词
cancer; risk; type; 2; diabetes; POPULATION-BASED COHORT; MELLITUS; PREVALENCE; MEN;
D O I
10.1111/1753-0407.12926
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundThe aim of this study was to investigate the risk of 23 common types of cancer among patients with type 2 diabetes (T2D) compared with the general Chinese population. MethodsBased on the Shanghai Hospital Link database, 410191 patients with T2D (age 20-99years) were identified from July 2013 to December 2016, and were followed-up for cancer incidence until December 2017. ResultsIn all, 8485 cases of newly diagnosed cancer were identified. The standardized incidence ratios (SIRs) of total cancer were 1.34 and 1.62 among males and females, respectively. Among males with T2D, the risk of cancer of the prostate (highest SIR of 1.86), blood (leukemia, lymphoma), skin, thyroid, kidney, liver, pancreas, lung, colorectum, and stomach was increased significantly. There was a significant decrease in the risk of esophageal cancer. In females with T2D, there were significantly greater risks of cancer of the nasopharynx (highest SIR of 2.33), liver, esophagus, thyroid, lung, pancreas, blood (lymphoma, leukemia), uterus, colorectum, breast, cervix, and stomach. In contrast, there was significantly decrease risk of gallbladder cancer in females with T2D. ConclusionsThis study shows significantly increased risks of overall and some site-specific cancers among patients with T2D. We suggest that establishing strategies for regular cancer-specific screening and prevention care among patients with T2D are necessary. ?? ???????????????,2????????23??????????? ?????????????,?2013?7??2016?12????410 191?2??????(??20-99?),????2017?12????????? ?????????8485???????????2?????????????????(standardized incidence ratios,SIRs)???1.34?1.62?????????,????(SIR??:1.86)???(???????)?????????????????????????????????????,???????????????????,???(SIR??:2.33)??????????????????????(???????)?????????????????????????????????,???????????????? ????????,2???????????????????????????????????????2???????????????????????
引用
收藏
页码:878 / 883
页数:6
相关论文
共 50 条
  • [1] Insulin glargine use and cancer risk among patients with type 2 diabetes mellitus: a real-world study in Shanghai, China
    Qi, Jiying
    He, Ping
    Yao, Huayan
    Sun, Wen
    Lu, Ping
    Zhang, Zizheng
    Cui, Bin
    Ning, Guang
    [J]. INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES, 2024, 44 (01) : 137 - 144
  • [2] Insulin glargine use and cancer risk among patients with type 2 diabetes mellitus: a real-world study in Shanghai, China
    Jiying Qi
    Ping He
    Huayan Yao
    Wen Sun
    Ping Lu
    Zizheng Zhang
    Bin Cui
    Guang Ning
    [J]. International Journal of Diabetes in Developing Countries, 2024, 44 : 137 - 144
  • [3] Insulin use and gout risk among patients with type 2 diabetes mellitus: a real-world cohort study in Shanghai, China
    Jiying Qi
    Ping He
    Huayan Yao
    Wen Sun
    Ping Lu
    Xiaohui Qi
    Zizheng Zhang
    Renjie Jing
    Bin Cui
    Dongmei Liu
    Guang Ning
    [J]. Clinical Rheumatology, 2023, 42 : 3067 - 3073
  • [4] Insulin use and gout risk among patients with type 2 diabetes mellitus: a real-world cohort study in Shanghai, China
    Qi, Jiying
    He, Ping
    Yao, Huayan
    Sun, Wen
    Lu, Ping
    Qi, Xiaohui
    Zhang, Zizheng
    Jing, Renjie
    Cui, Bin
    Liu, Dongmei
    Ning, Guang
    [J]. CLINICAL RHEUMATOLOGY, 2023, 42 (11) : 3067 - 3073
  • [5] REAL-WORLD TREATMENT PATTERN IN COMMUNITY PATIENTS WITH TYPE-2 DIABETES: EVIDENCE FROM SHANGHAI, CHINA
    Gao, Y.
    Chen, L.
    Fang, H.
    Xu, D.
    Xuan, J.
    Liu, B.
    [J]. VALUE IN HEALTH, 2016, 19 (07) : A680 - A680
  • [6] Real-World Study on the Effect of SGLT2 Inhibitors in Patients with Type 2 Diabetes in China
    Xue, Yaoming
    Shi, Lixin
    Yu, Xuefeng
    Wang, Yangang
    Hong, Tianpei
    Li, Xiaoying
    Ma, Jianhua
    Zhu, Dalong
    Mu, Yiming
    [J]. DIABETES, 2024, 73
  • [7] Delays in Insulin Initiation among Patients with Type 2 Diabetes Mellitus in Southeast China: A Retrospective, Real-World Study
    Chen, Pin
    Ma, Xiao
    Chen, Hong
    Wang, Ke
    Zhou, Li
    [J]. DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2020, 13 : 3059 - 3068
  • [8] Trends and Gaps in Statin Use for Cardiovascular Disease Prevention in Type 2 Diabetes: A Real-World Study in Shanghai, China
    Jing, Renjie
    Yao, Huayan
    Yan, Qun
    Xue, Yanbin
    Sun, Wen
    Lu, Ping
    Zhang, Zizheng
    Xie, Rui
    Cui, Bin
    Feng, Bo
    [J]. ENDOCRINE PRACTICE, 2023, 29 (10) : 747 - 753
  • [9] Risk of Death and Heart Failure among Patients with Type 2 Diabetes Treated by Metformin and Nonmetformin Monotherapy: A Real-World Study
    He, Siyao
    Qian, Xin
    Chen, Yanyan
    Shen, Xiaoxia
    Zhang, Bo
    Chen, Xiaoping
    Xu, Xiangjin
    Li, Guangwei
    [J]. JOURNAL OF DIABETES RESEARCH, 2021, 2021
  • [10] Multimorbidity and achievement of treatment goals among patients with type 2 diabetes: a primary care, real-world study
    Eveliina Heikkala
    Ilona Mikkola
    Jari Jokelainen
    Markku Timonen
    Maria Hagnäs
    [J]. BMC Health Services Research, 21